Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


After Decade Of Settlements And CIAs, Omnicare Faces Another DOJ Complaint

Executive Summary

Government alleges Omnicare and its parent CVS Health filled thousands of invalid prescriptions to elderly and disabled individuals; suit follows nine settlements and two corporate integrity agreements since 2006.

You may also be interested in...

Omnicare Settlement With DoJ Shows Power Of Nursing Homes In Driving Rxs

Omnicare's settlement with the Department of Justice to resolve kickback allegations was remarkable for the breadth and complexity of the government's case. But it also cast attention on a particular segment of the pharmaceutical market: nursing homes

A Closer Look: Health Care Fraud Investigations In Pharma Sector Take New Twists

Purdue Frederick's plea agreement with the government over its OxyContin promotion sent ripples through the pharmaceutical industry

Pharma Industry Broadens Its Approach To Expanded Access

Novartis co-leads industry forum on preapproval access that aims to share best practices and engage patient groups; Janssen is launching three pilots to leverage collection of preapproval access data.


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts